ASC-话题@MedSci

#ASC#

1352篇内容 | 4002人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1939314, encodeId=66a019393149a, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：心肌损伤后葡萄糖依赖性促胰岛素肽会反应性下调, objectType=article, longId=295507, objectId=d95229550e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d95229550e83, replyNumber=0, likeNumber=84, createdTime=2022-06-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d95229550e83, moduleTitle=Cardiovasc Diabetol：心肌损伤后葡萄糖依赖性促胰岛素肽会反应性下调, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d95229550e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939258, encodeId=296e193925872, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Ardiovasc Diabetol：TyG指数与亚临床动脉粥样硬化相关性的性别差异, objectType=article, longId=218809, objectId=2d56218809c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d56218809c5, replyNumber=0, likeNumber=83, createdTime=2021-11-06, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d56218809c5, moduleTitle=Ardiovasc Diabetol：TyG指数与亚临床动脉粥样硬化相关性的性别差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d56218809c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939262, encodeId=6b8519392620f, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=FDA 批准Scemblix（asciminib）治疗慢性粒细胞白血病, objectType=article, longId=219579, objectId=ee952195e949, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee952195e949, replyNumber=0, likeNumber=106, createdTime=2022-06-08, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee952195e949, moduleTitle=FDA 批准Scemblix（asciminib）治疗慢性粒细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee952195e949)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939193, encodeId=21ee193919365, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2021：非小细胞肺癌专场--口头报告(02), objectType=article, longId=212344, objectId=1a5d21234499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a5d21234499, replyNumber=0, likeNumber=68, createdTime=2022-01-29, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a5d21234499, moduleTitle=ASCO 2021：非小细胞肺癌专场--口头报告(02), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a5d21234499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939219, encodeId=14c9193921914, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用, objectType=article, longId=212564, objectId=6f2921256483, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2921256483, replyNumber=0, likeNumber=68, createdTime=2022-01-31, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2921256483, moduleTitle=Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2921256483)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939349, encodeId=70241939349f3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：急性ST段抬高心肌梗死患者应激性高血糖比率的预测价值, objectType=article, longId=725802, objectId=163fe25802d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=163fe25802d9, replyNumber=0, likeNumber=107, createdTime=2022-10-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=163fe25802d9, moduleTitle=Cardiovasc Diabetol：急性ST段抬高心肌梗死患者应激性高血糖比率的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=163fe25802d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939247, encodeId=8c7e193924eef, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JACC：高敏C反应蛋白可显著改变脂蛋白a相关ASCVD的风险, objectType=article, longId=217555, objectId=51ad21e55578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51ad21e55578, replyNumber=0, likeNumber=81, createdTime=2022-06-02, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51ad21e55578, moduleTitle=JACC：高敏C反应蛋白可显著改变脂蛋白a相关ASCVD的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51ad21e55578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939246, encodeId=a100193924632, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：卡格列净对2型糖尿病合并慢性心衰患者NT-proBNP水平的影响, objectType=article, longId=217248, objectId=505d21e2487a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=505d21e2487a, replyNumber=0, likeNumber=62, createdTime=2022-07-10, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=505d21e2487a, moduleTitle=Cardiovasc Diabetol：卡格列净对2型糖尿病合并慢性心衰患者NT-proBNP水平的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=505d21e2487a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939251, encodeId=579a1939251f4, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Res：肺动脉高压内皮细胞的单细胞测序分析, objectType=article, longId=217864, objectId=b58f21e864e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b58f21e864e1, replyNumber=0, likeNumber=130, createdTime=2022-07-25, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b58f21e864e1, moduleTitle=Cardiovasc Res：肺动脉高压内皮细胞的单细胞测序分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b58f21e864e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939178, encodeId=cd2619391e8ab, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2021：摘要概览与展望12 | 阿斯利康全新数据支持通过更早治疗和改变患者体验来彻底改变癌症结局的雄心壮志, objectType=article, longId=211960, objectId=5d5621196063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d5621196063, replyNumber=0, likeNumber=85, createdTime=2021-09-29, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d5621196063, moduleTitle=ASCO 2021：摘要概览与展望12 | 阿斯利康全新数据支持通过更早治疗和改变患者体验来彻底改变癌症结局的雄心壮志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d5621196063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939207, encodeId=425e193920ea5, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO2021：免疫表达信号可预测转移性结直肠癌的治疗反应和生存, objectType=article, longId=212453, objectId=d5bf212453c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5bf212453c8, replyNumber=0, likeNumber=59, createdTime=2021-12-30, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5bf212453c8, moduleTitle=ASCO2021：免疫表达信号可预测转移性结直肠癌的治疗反应和生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5bf212453c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939294, encodeId=3aae1939294a3, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效, objectType=article, longId=293013, objectId=9da72930139e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da72930139e, replyNumber=0, likeNumber=60, createdTime=2022-12-13, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da72930139e, moduleTitle=ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da72930139e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939161, encodeId=8278193916174, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重，查一下CMRA, objectType=article, longId=211508, objectId=238c21150815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=238c21150815, replyNumber=0, likeNumber=0, createdTime=2021-08-02, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=238c21150815, moduleTitle=Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重，查一下CMRA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=238c21150815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939190, encodeId=827c1939190ae, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle= ASCO 2021：摘要概览与展望21 | zenocutuzumab治疗晚期胰腺癌、NRG1融合实体肿瘤的有效性和安全性, objectType=article, longId=212300, objectId=666a21230082, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=666a21230082, replyNumber=0, likeNumber=96, createdTime=2022-01-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=666a21230082, moduleTitle= ASCO 2021：摘要概览与展望21 | zenocutuzumab治疗晚期胰腺癌、NRG1融合实体肿瘤的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=666a21230082)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939313, encodeId=dec8193931346, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：糖尿病前期患者血浆载脂蛋白浓度与糖尿病发生率的关系, objectType=article, longId=295435, objectId=094a295435a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094a295435a3, replyNumber=0, likeNumber=66, createdTime=2022-04-24, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094a295435a3, moduleTitle=Cardiovasc Diabetol：糖尿病前期患者血浆载脂蛋白浓度与糖尿病发生率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094a295435a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939240, encodeId=2b30193924002, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病, objectType=article, longId=215987, objectId=73ce21598e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ce21598e81, replyNumber=0, likeNumber=93, createdTime=2022-05-16, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ce21598e81, moduleTitle=JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73ce21598e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939328, encodeId=dc271939328b0, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol ：利拉鲁肽与生活方式改变对肥胖糖尿病前期患者或减肥后的2型糖尿病患者Sst2和Galectin-3的影响, objectType=article, longId=300967, objectId=04cb30096e54, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04cb30096e54, replyNumber=0, likeNumber=63, createdTime=2022-07-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04cb30096e54, moduleTitle=Cardiovasc Diabetol ：利拉鲁肽与生活方式改变对肥胖糖尿病前期患者或减肥后的2型糖尿病患者Sst2和Galectin-3的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04cb30096e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939235, encodeId=2855193923559, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=JACC发布高甘油三酯血症患者降低ASCVD风险的临床指南, objectType=article, longId=215019, objectId=7d0e21501983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d0e21501983, replyNumber=0, likeNumber=0, createdTime=2022-02-15, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d0e21501983, moduleTitle=JACC发布高甘油三酯血症患者降低ASCVD风险的临床指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d0e21501983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939179, encodeId=dd2b19391e921, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=ASCO 2021：摘要概览与展望13|非小细胞肺癌专题研究速递(01), objectType=article, longId=211970, objectId=fbf92119e042, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbf92119e042, replyNumber=0, likeNumber=72, createdTime=2022-02-18, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbf92119e042, moduleTitle=ASCO 2021：摘要概览与展望13|非小细胞肺癌专题研究速递(01), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbf92119e042)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1939250, encodeId=5c22193925085, content=<a href='/topic/show?id=1c292818fd' target=_blank style='color:#2F92EE;'>#ASC#</a>, objectTitle=Cardiovasc Diabetol：Meta 分析显示GLP-1受体激动剂对主要心血管事件具有中度获益, objectType=article, longId=217820, objectId=f24821e820ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f24821e820ef, replyNumber=0, likeNumber=95, createdTime=2022-09-03, rootId=0, userName=quxin068, userId=74808, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f24821e820ef, moduleTitle=Cardiovasc Diabetol：Meta 分析显示GLP-1受体激动剂对主要心血管事件具有中度获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f24821e820ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASC

2020-05-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：心肌损伤后葡萄糖依赖性促胰岛素肽会反应性下调

2022-06-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Ardiovasc Diabetol：TyG指数与亚临床动脉粥样硬化相关性的性别差异

2021-11-06

quxin068 (审核中...)

前往app查看评论内容

#ASC#

FDA 批准Scemblix（asciminib）治疗慢性粒细胞白血病

2022-06-08

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021：非小细胞肺癌专场--口头报告(02)

2022-01-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Agendia在ASCO 2021上呈报创新性FLEX研究的数据，展示MammaPrint和BluePrint对广大类别患者群体的效用

2022-01-31

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：急性ST段抬高心肌梗死患者应激性高血糖比率的预测价值

2022-10-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JACC：高敏C反应蛋白可显著改变脂蛋白a相关ASCVD的风险

2022-06-02

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：卡格列净对2型糖尿病合并慢性心衰患者NT-proBNP水平的影响

2022-07-10

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Res：肺动脉高压内皮细胞的单细胞测序分析

2022-07-25

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021：摘要概览与展望12 | 阿斯利康全新数据支持通过更早治疗和改变患者体验来彻底改变癌症结局的雄心壮志

2021-09-29

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO2021：免疫表达信号可预测转移性结直肠癌的治疗反应和生存

2021-12-30

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO-2021速递：光谱MRI可指导胶质母细胞瘤放疗，安全有效

2022-12-13

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Journal of Cardiovascular Magnetic Resonance:冠脉狭窄是否严重，查一下CMRA

2021-08-02

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021：摘要概览与展望21 | zenocutuzumab治疗晚期胰腺癌、NRG1融合实体肿瘤的有效性和安全性

2022-01-03

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：糖尿病前期患者血浆载脂蛋白浓度与糖尿病发生率的关系

2022-04-24

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JNNP：IgG1 Pan-Neurofascin 抗体确定了一种严重但可治疗且死亡率高的神经疾病

2022-05-16

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol ：利拉鲁肽与生活方式改变对肥胖糖尿病前期患者或减肥后的2型糖尿病患者Sst2和Galectin-3的影响

2022-07-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

JACC发布高甘油三酯血症患者降低ASCVD风险的临床指南

2022-02-15

quxin068 (审核中...)

前往app查看评论内容

#ASC#

ASCO 2021：摘要概览与展望13|非小细胞肺癌专题研究速递(01)

2022-02-18

quxin068 (审核中...)

前往app查看评论内容

#ASC#

Cardiovasc Diabetol：Meta 分析显示GLP-1受体激动剂对主要心血管事件具有中度获益

2022-09-03

科室
- - 订阅+
  - 更多科室
工具
服务